Psychological problems in patients with type 2 diabetes – Clinical considerations

Žana Branislav Stanković; Miroslava Jašović-Gašić; Dušica Lečić-Toševski

doi:10.2298/1835

Žana Branislav Stanković Clinic for Psychiatry, Clinical Centre of Serbia, Belgrade, Serbia
Miroslava Jašović-Gašić Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Dušica Lečić-Toševski Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Institute of Mental Health, Belgrade, Serbia

DOI: https://doi.org/10.2298/1835

Keywords: diabetes mellitus, type 2, comorbitidy, mental health, mental disorders, quality of life, therapeutics,

Abstract

Author Biography

Žana Branislav Stanković, Clinic for Psychiatry, Clinical Centre of Serbia, Belgrade, Serbia

Žana B. Stanković

Postgraduate studies:

- 2011 Doctor of science (PhD) (Psychiatry) – Medical Faculty, University in Belgrade

-2004 Master of Science (MSc) (Biological Psychiatry) – Medical Faculty, University in Belgrade

-1995 Subspecialization in Clinical Pharmacology – Medical Faculty, University in Belgrade

-1987 Specialization in Neuropsychiatry – Medical Faculty, University in Belgrade

1979 Graduated from Faculty of Medicine (MD) – Medical Faculty, University in Nis

1996 American Biographical Institute Award

2001 Title of Primarius - Ministry of Health of Republic of Serbia

Present position: Head of Outpatients Department at Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade

1990-2001 Clinical Department for Affective Disorders at Institute of Psychiatry, University Clinical Centre of Serbia, Belgrade

1988-1990 Institute for Disorders of Dependence, Belgrade, Drajzerova 44

1982-1988 Health Centre in Smederevo – General Practice, Residency

1981-1982 Pharmaceutical Company Pliva, Zagreb - Product Manager

1980 Clinical Centre in Nis - Internship

Member of:

-Presidency of Serbian Medical Association (2007-2009)

-Presidency of Psychiatric Section of Serbian Medical Association (2001-2006)

-Serbian Psychiatric Association (SPA) (2007-)

-European Psychiatric Association (EPA) (2005-)

-Editorial Board of Engrami (2005-)

-Serbian Pharmacological Society (2004- )

-Clinical Pharmacology Section of Serbian Medical Association (2009- )

-Pharmacotherapy Section of Serbian Medical Association (1995- )

Spacial field of interest: Psychotic disorders, Psychopharmacology, Consultation-Liaisone Psychiatry

Education of residents in General Medicine

84 articles in iternational and national journals, first or sole author in 62 (74%)

Guest reviwer for Journal of Affective Disorders (Current Content), Neuropsychiatric Disease and Treatment and the Journal of Diabetology

Partitipation in numerous international and national congresses, seminars, meetings and symposia

Member of the Organizing and Scientific Committee of several national symposia and a member of the Organizing Committee of the International Symposium

Lecturer at conferences in the Continuing Medical Education (CME)

Investigatior in several clinical studies; Collaboration with ICON (indipendent transletor in clinical studies, 1996 and 2003)

Oral Presentation at the World Congress of Biological Psychiatry in Nice, 1997

Oral presentation at the Congress of European Psychiatrists in London, 1996

Prim. Žana Stanković, MD, MSc, PhD

Specialist in Neuropsychiatry and Clinical Pharmacology

Head of Outpatients Department

Clinic for Psychiatry, Clinical Centre of Serbia

11000 Belgrade, Pasterova 2

Serbia

Tel (work): + 381 11 2683 - 093; 366 - 2090

(home): + 381 11 3564 - 821; 3056 - 590

Cell: + 381 64 439 74 96; + 381 66 83 00 847

fax: + 381 11 2645 - 543

E-mail: stankovic.zana@gmail. com; zana.s@verat.net

References

Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns 2007; 68(1): 10−5.

American Diabetes Association: American Diabetes Associa-tion Complete Guide to Diabetes. Alexandria, Va: American Diabetes Association; 1999.

Atanacković-Marković Z, Bjegović J, Janković S, Kocev N, Laaser U, Marinković J. The Burden of Disease and Injury in Serbia. Ser-bian Burden of Disease Study. Belgrade: Ministry of Health of the Republic Serbia; 2003.

Koopmanschap M. CODE-2 Advisory Board. Coping with Type II diabetes: the patient’s perspective. Diabetologia 2002; 45(7): S18–22.

Lecic Tosevski D, Pejovic Milovancevic M. Stressful life events and physical health. Curr Opin Psychiatry 2006; 19(2): 184–9.

Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet Med 1999; 16(5): 373–83.

Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196(4286): 129–36.

Polonsky WH, Welch G. Listening to our patients’ concerns: un-derstanding and addressing diabetes-specific emotional dis-tress. Diabetes Spectrum 1996; 9(1): 8–11.

Black SA, Ray LA, Markides KS. The prevalence and health burden of self-reported diabetes in older Mexican Americans: findings from the Hispanic established populations for epide-miologic studies of the elderly. Am J Public Health 1999; 89(4): 546–52.

Rubin RR, Payrot M. Psychological Issues and Treatments for People with Diabetes. J Clin Psychol 2001; 57(4): 457−78.

American Diabetes Association. Diabetes 1996 vital statistics. Al-exandria, VA: American Diabetes Association, 1996.

Almawi W, Tamim H, Al-Sayed N, Arekat MR, Al-Khateeb GM, Baqer A, et al. Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J Endocrinol Invest 2008; 31(11): 1020–4.

Das-Munshi J, Stewart R, Ismail K, Bebbington PE, Jenkins R, Prince MJ. Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey. Psychosom Med 2007; 69(6): 543–50.

Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: Findings from the 2006 behavioral risk factor surveillance system. Diabet Med 2008; 25(7): 878–81.

Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: A systematic re-view. J Psychosom Res 2002; 53(6): 1053–60.

Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24(6): 1069–78.

Gale CR, Kivimaki M, Lawlor DA, Carroll D, Phillips AC, Batty GD. Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam experience study. Biol Psychiatry 2010; 67(2): 189–92.

Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G. Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan. Diabetol Metab Syndr 2010; 2(1): 17.

Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31(12): 2383–90.

Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160(21): 3278–85.

Katon WJ. The comorbidity of diabetes mellitus and depres-sion. Am J Med 2008; 121(11): 8–15.

Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE. Fac-tors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 2007; 30(3): 459–66.

Abrahamian H, Hofmann P, Prager R, Toplak H. Diabetes melli-tus and co-morbid depression: treatment with milnacipran re-sults in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat 2009; 5: 261–6.

Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007; 69(3): 235–41.

Choi YJ, Lee MS, An SY, Kim TH, Han SJ, Kim HJ, et al. The Relationship between Diabetes Mellitus and Health-Related Quality of Life in Korean Adults: The Fourth Korea National Health and Nutrition Examination Survey (2007-2009). Diabetes Metab J 2011; 35(6): 587–94.

Aikens JE, Perkins DW, Piette JD, Lipton B. Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimen. Diabet Med 2008; 25(11): 1324–9.

Egede LE, Ellis C. The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes. Diabetes Technol Ther 2010; 12(4): 257–62.

Stanković Ž. Psycho-social, clinical and neurobiological corre-lates of depresion in patients with type 2 diabetes [disserta-tion]. Belgrade: Faculty of Medicine, University of Belgrade; 2011. (Serbian).

Stanković Ž, Nikolić-Balkoski G, Leposavić Lj, Popović Lj. Percep-tion of quality of life and social adjustment of patients with recurrent depression. Srp Arh Celok Lek 2006; 134 (9−10): 369–74. (Serbian)

Dalvi M, Feher M, Caglar E, Catalan J. Liaison psychiatrist in a specialist diabetes centre. The Psychiatrist 2008; 32: 461–3.

Banerjea R, Sambamoorthi U, Smelson D, Pogach, L. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res 2008; 35(3): 290–303.

Prisciandaro JJ, Gebregziabher M, Grubaugh AL, Gilbert GE, Echols C, Egede LE. Impact of psychiatric comorbidity on mortality in veterans with type 2 diabetes. Diabetes Technol Ther 2011; 13(1): 73–8.

Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffec-tive disorders independent of psychotropic drug use. J Affect Disord 2002; 70(1):19–26.

Lin PI, Shuldiner AR. Rethinking the genetic basis for comor-bidity of schizophrenia and type 2 diabetes. Schizophr Res 2010; 123(2−3): 234–43.

Luchsinger JA. Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention? J Alzheimers Dis 2010; 20(3): 723–36.

Skovlund SE, Peyrot M.. The Diabetes Attitudes, Wishes, and Needs (DAWN) program: a new approach to improving out-comes of diabetes care. Diabetes Spectrum 2005; 18(3): 136–42.

Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skov-lund SE. Psychosocial problems and barriers to improved dia-betes management: results of the cross-national Diabetes Atti-tudes, Wishes, and Needs study. Diabet Med 2005; 22(10): 1379–85.

Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical Depression Versus Distress Among Patients With Type 2 Diabetes: Not just a question of semantics. Dia-betes Care 2007; 30(3): 542–8.

Polonsky WH, Anderson BJ, Lohler PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes related distress. Diabetes Care 1995; 18(6):754–60.

Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. De-pressive symptoms and metabolic control in African Ameri-cans with type 2 diabetes. Diabetes Care 2000; 23(1): 23–9.

Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care 1994; 17(10): 1178–85.

Ogbera A, Adeyemi-Doro A. Emotional distress is associated with poor self care in type 2 diabetes mellitus. J Diabetes 2011; 3(4): 348–52.

Ting RZ, Nan H, Yu MV, Kong AP, Ma RC, Wong RY, et al. Diabetes-Related Distress and Physical and Psychological Health in Chinese Type 2 Diabetic Patients. Diabetes Care 2011; 34(5):1094–6.

Graue M, Haugstvedt A, Wentzel-Larsen T, Iversen MM, Karlsen B, Rokne B. Diabetes-related emotional distress in adults: Reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud 2012; 49(2):174–8.

Shakibazadeh E, Rashidian A, Larijani B, Shojaeezadeh D. Psy-chometric Properties of the Iranian Version of Resources and Support for Chronic Illness Self-management Scale in Patients with Type 2 Diabetes. Int J Prev Med 2012; 3(2): 84–90.

Nozaki T, Morita C, Matsubayashi S, Ishido K, Yokoyama H, Kawai K, et al. Relation between psychosocial variables and the glycemic control of patients with type 2 diabetes: a cross-sectional and prospective study. Biopsychosoc Med 2009; 3: 4.

Nakahara R, Yoshiuchi K, Kumano H, Hara Y, Suematsu H, Kuboki T. Prospective study on influence of psychosocial factor on glycemic control in Japanese patients with type 2 diabetes. Psychosomatics 2006; 47(3): 240–6.

Zagarins SE, Allen NA, Garb JL, Welch G. Improvement in glycemic control following a diabetes education intervention is associated with change in diabetes distress but not change in depressive symptoms. J Behav Med 2012; 35(3):299–304.

Leyva B, Zagarins SE, Allen NA, Welch G. The relative impact of diabetes distress vs. depression on glycemic control in His-panic patients following a diabetes self-management education intervention. Ethn Dis 2011; 21(3): 322–7.

Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010; 33(1): 23–8.

Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care 2010; 33(5):1034–6.

Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, et al. Association of diabetes-related emotional dis-tress with diabetes treatment in primary care patients with Type 2 diabetes. Diabet Med 2007; 24(1): 48–54.

Makine C, Karşidağ C, Kadioğlu P, Ilkova H, Karşidağ K, Skovlund S, et al. Symptoms of depression and diabetes-specific emo-tional distress are associated with a negative appraisal of insu-lin therapy in insulin-naïve patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med 2009; 26(1): 28–33.

Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Mat-thews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28(11): 2673–9.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047–53.

Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28(10): 2543–5.

Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18(1): 23–32.

Peyrot M, Rubin RR, Siminerio LM. Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006; 29(6):1256–62.

Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associ-ated with psychological insulin resistance in individual with type 2 diabetes. Diabetes Care 2010; 33(8):1747–9.

Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: Psychological comorbidity and general well-being. J Psychosom Res 2001; 51(5): 665–72.

Fisher L, Mullan JT, Skaff MM, Glasgow RE, Arean P, Hessler D. Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study. Diabet Med 2009; 26(6): 622–7.

Yi JP, Yi JC, Vitaliano PP, Weinge K. How Does Anger Coping Style Affect Glycemic Control in Diabetes Patients? Int J Behav Med 2008; 15(3): 167–72.

Karlsen B, Bru E. Coping styles among adults with type 1 and type 2 diabetes. Psychol Health Med 2002; 7(3): 245–59.

Tuncay T, Musabak I, Gok DE, Kutlu M. The relationship be-tween anxiety, coping strategies and characteristics of patients with diabetes. Health Qual Life Outcomes 2008; 6: 79.

Karlsen B, Oftedal B, Bru E. The relationship between clinical indicators, coping styles, perceived support and diabetes-related distress among adults with type 2 diabetes J Adv Nurs 2012; 68(2): 391−401.

Gois C, Barbosa A, Ferro A, Santos AL, Sousa F, Akiskal H, et al. The role of affective temperaments in metabolic control in patients with type 2 diabetes. J Affect Disord 2011; 134(1−3): 52–8.

Stanković Ž, Jašović-Gašić M. Comorbidity of depression and type 2 diabetes–risk factors and clinical significance. Vojno-sanit Pregl 2010; 67(6): 493–500. (Serbian)

Kokoszka A, Pouwer F, Jodko A, Radzio R, Mućko P, Bieńkowska J, et al. Serious diabetes-specific emotional problems in pa-tients with type 2 diabetes who have different levels of comorbid depression: a Polish study from the European Depression in Diabetes (EDID) Research Consortium. Eur Psychiatry 2009; 24(7): 425–30.

Hosoya T, Matsushima M, Nukariya K, Utsunomiya K. The rela-tionship between the severity of depressive symptoms and diabetes-related emotional distress in patients with type 2 dia-betes. Intern Med 2012; 51(3): 263–9.

Pibernik-Okanovic M, Begic D, Peros K, Szabo S, Metelko Z. Psy-chosocial factors contributing to persistent depressive symp-toms in type 2 diabetic patients: a Croatian survey from the European Depression in Diabetes Research Consortium. J Diabetes Complications 2008; 22(4): 246–53.

Huis In 't Veld EM, Makine C, Nouwen A, Karşıdağ C, Kadıoğlu P, Karşıdağ K, et al. Validation of the Turkish version of the problem areas in diabetes scale. Cardiovasc Psychiatry Neurol 2011; 2011: 315068.

van Bastelaar KM, Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AT, et al. Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabet Med 2010; 27(7): 798–803.

Welch G, Zagarins SE, Feinberg RG, Garb JL. Motivational interviewing delivered by diabetes educators: Does it improve blood glucose control among poorly controlled type 2 diabetes patients. Diabetes Res Clin Pract 2011; 91(1): 54–60.

Stanković Ž, Jašović-Gašić M, Zamaklar M. Psycho-social and clinical variables associated with depression in patients with type 2 diabetes. Psychiatr Danub 2011; 23(1): 34–44.

Peyrot M, Rubin RR. Behavioral and Psychosocial Interventions in Diabetes: A conceptual review. Diabetes Care 2007; 30(10): 2433–40.

Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006; 49(3): 469–77.

McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia 2010; 53(1): 66–9.

Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson- Triche M, Wells K. Who is at Risk of Nondetection of Mental Health Problems in Primary Care? J Gen Intern Med 2000; 15(6): 381–8.

Casey P, Bailey S. Adjustment disorders: the start of the art. World Psychiatry 2011; 10(1): 11–8.

Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. De-velopment of a Brief Diabetes Distress Screening Instrument. Ann Fam Med 2008; 6(3): 246–52.

Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have we been missing something important? Diabetes Care 2011; 34(1): 236–9.

Hermanns N, Kulzer B, Maier B, Mahr M, Haak T. The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes. Patient Educ Couns 2012; 86(2): 226–32.

Hill-Briggs F, Lazo M, Peyrot M, Doswell A, Chang YT, Hill MN, et al. Effect of problem-solving-based diabetes self-management training on diabetes control in a low income pa-tient sample. J Gen Intern Med 2011; 26(9): 972–8.

Plack K, Herpertz S, Petrak F. Behavioral medicine interventions in diabetes. Curr Opin Psychiatry 2010; 23(2): 131–8.